Company intelligence / Profile preview

EnsiliTech

Bath, England, United Kingdomensilitech.com ↗

Ownership: Private
Development stage: Preclinical

Overview

No clinical results reported. The company’s ensilication technology has demonstrated the ability to stabilize biological products at temperatures from –80°C to +50°C, eliminating the need for cold-chain logistics and improving shelf-life. Applications are being explored for both existing and new biopharmaceutical formulations.

Therapeutic areas: Infectious Diseases
Modalities: Biologicals (including vaccines, antibodies, and other biomolecules)
Industry: Non-Drug Biotech

Partnerships

Supported by Innovate UK and seeking additional partners in pharma/biotech sectors

Beyond the preview

Go deeper on EnsiliTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EnsiliTech.

Explore the full profile